![]() |
|
|
Vol. 59, Issue 5, 1100-1107, May 2001
Department of Biology, State University of New York at Albany, Albany, New York (S.-Y.W.); and Department of Anesthesia, Harvard Medical School and Brigham & Women's Hospital, Boston, Massachusetts (M.B., G.K.W.)
| |
Abstract |
|---|
|
|
|---|
Batrachotoxin (BTX) stabilizes the voltage-gated Na+
channels in their open conformation, whereas local anesthetics (LAs)
block Na+ conductance. Site-directed mutagenesis has
identified clusters of common residues at D1-S6, D3-S6, and D4-S6
segments within the
-subunit Na+ channel that are
critical for binding of these two types of ligands. In this report, we
address whether segment D2-S6 is similarly involved in both BTX and LA
actions. Thirteen amino acid positions from G783 to L795 of the rat
skeletal muscle Na+ channel (µ1/Skm1) were individually
substituted with a lysine residue. Four mutants (N784K, L785K, V787K,
and L788K) expressed sufficient Na+ currents for further
studies. Activation and/or inactivation gating was altered in mutant
channels; in particular, µ1-V787K displays enhanced slow inactivation
and exhibited use-dependent inhibition of peak Na+ currents
during repetitive pulses. Two of these four mutants, µ1-N784K and
µ1-L788K, were completely resistant to 5 µM BTX. This BTX-resistant
phenotype could be caused by structural perturbations induced by a
lysine point mutation in the D2-S6 segment. However, these two
BTX-resistant mutants remained quite sensitive to bupivacaine block
with affinity for inactivated Na+ channels
(KI) of ~10 µM or less, which suggests
that µ1-N784 and µ1-L788 residues are not in close proximity to the
LA binding site.
| |
Introduction |
|---|
|
|
|---|
The
voltage-gated Na+ channels are membrane proteins
responsible for the generation of action potentials in excitable
membranes. In mammalian cells, the Na+ channel
family contains one large
subunit and one or two smaller
auxiliary subunits (
1,
2) (Catterall, 2000
). The
-subunit clone consists of about 2000 amino acids and, when expressed alone in
mammalian cells, exhibits functional Na+ currents
with gating kinetics comparable with those of the native Na+ channels. The
-subunit primary sequence
contains four homologous domains (D1-D4), each with six transmembrane
segments (S1-S6) (Fig. 1A). Current
structural models suggest that the Na+ channel is
organized as a pseudotetramer with S6 segments possibly lining the
internal vestibule of the pore.
|
Local anesthetics (LAs) block voltage-gated Na+
channels in a complicated state-dependent manner. LAs seem to have
higher affinities toward open and inactivated states (Strichartz, 1973
;
Courtney, 1975
). In contrast, a steroidal alkaloid toxin, batrachotoxin (BTX), isolated from poison-dart frogs, inhibits both
Na+ channel fast and slow inactivation and shifts
the activation threshold to the hyperpolarizing direction (Khodorov,
1978
). Consequently, the Na+ channel opens
readily with BTX present, even at the resting membrane potential. The
receptors for LAs and BTX have been mapped within S6 segments of
domains D1, D3, and D4 with several common residues important for
binding of both LAs and BTX (Fig. 1B; Ragsdale et al., 1994
; Wang and
Wang, 1998
, 1999
; Linford et al., 1998
; Vedantham and Cannon, 2000
;
Wang et al., 2000
). Furthermore, a quaternary derivative of lidocaine,
QX-314, can access the LA receptor of the neuronal
Na+ channels only via internal application
(Strichartz, 1973
). These findings together imply that S6 segments are
closely aligned to form the internal vestibule of the
Na+ permeation pathway. Detailed mapping of S6
segments may therefore reveal the architecture of this pore region.
The fact that LAs can accelerate the dissociation rate of BTX from its
receptor (Postma and Catterall, 1984
) suggests that both LAs and BTX
can bind simultaneously. Consistent with this result, LAs block single,
BTX-modified Na+ channels incorporated in lipid
bilayers, apparently in a one LA to one BTX-modified channel
relationship (Moczydlowski et al., 1986
; Wang, 1988
). The previous
explanation for these observations is that BTX allosterically affects
the binding affinity of LAs toward their receptor in
Na+ channels and vice versa. However, recent
studies based on site-directed mutagenesis now revise this view. It was
suggested that different surfaces of common residues are important for
BTX and LA binding (Linford et al., 1998
) or, alternatively, that
common residues are involved in BTX and LA binding in a state-dependent
manner (Wang et al., 2000
). Thus, studies of the involvement of S6
segments in BTX and LA actions will be essential for understanding the physiological consequences of these ligands.
In this report, we address two unsettled questions. First, we asked whether segment D2-S6 is involved in BTX action. We created a series of lysine mutants within this region and measured the mutants' BTX sensitivity. Two mutants became completely resistant to BTX modification. Second, we asked whether these BTX-resistant mutant channels also become resistant to LA. Surprisingly, they remained relatively sensitive to bupivacaine block.
| |
Materials and Methods |
|---|
|
|
|---|
Site-Directed Mutagenesis.
Point mutations of a µ1
Na+ channel clone (Trimmer et al., 1989
) in a
pcDNA1/Amp expression vector were performed as described previously
(Nau et al., 1999
) by means of the Transformer Site-Directed Mutagenesis Kit (CLONTECH, Palo Alto, CA). A mutagenesis primer and a
restriction primer were used to generate the desired mutant. The
potential mutants were selected and confirmed by DNA sequencing at the
mutated site with appropriate primers.
Transient Transfection.
The culture of HEK293t cells and
their transient transfection were performed as described previously
(Cannon and Strittmatter, 1993
). Cells were first grown to 50%
confluence in Dulbecco's modified Eagle's medium (Life
Technologies, Grand Island, NY) containing 10% fetal bovine serum
(HyClone, Logan, UT), 1% penicillin and streptomycin solution (Sigma,
St. Louis, MO), 3 mM taurine, and 25 mM HEPES (Life Technologies).
Transfection of these cells with µ1 (10 µg) and reporter plasmid
CD8-pih3 m (1 µg) was accomplished by a calcium phosphate
precipitation method in a Ti25 flask. Cells were replated 15 h
after transfection, maintained at 37°C in a 5%
CO2 incubator, and used for experiments after 1 to 4 days, generally. However, mutant µ1-V787K usually did not
express sufficient currents until day 4. Transfection-positive cells
were identified by immunobeads (CD8-Dynabeads; Dynal, Lake Success, NY).
Whole-Cell Voltage Clamp.
The whole-cell configuration of a
patch-clamp technique (Hamill et al., 1981
) was used to record
Na+ currents in cells coated with CD8
immunobeads. Experiments were performed at room temperature (23 ± 2°C). Glass electrodes contained 100 mM NaF, 30 mM NaCl, 10 mM EGTA,
and 10 mM HEPES adjusted to pH 7.2 with CsOH. The electrodes had a tip
resistance of 0.5 to 1.0 M
; access resistance was generally
2 to 3 M
. With series resistance compensation of 60 to 90%, the
voltage error at +50 mV was < 4 mV on average. Series resistance
errors with this magnitude are generally tolerable because quantitative
measurements of current kinetics and drug block are insignificantly
affected by such errors (Bean, 1992
). The bath solution contained 65 mM
NaCl, 85 mM choline chloride, 2 mM CaCl2, and 10 mM HEPES adjusted to pH 7.4 with tetramethyl hydroxide. These ionic
conditions resulted in smaller Na+ currents at
voltages from
60 to +10 mV, which in turn minimized the series
resistance artifact in the conductance-voltage measurement. Stock
solution of bupivacaine was prepared at 100 mM in aqueous solution and
stored at
20°C until needed. BTX was prepared at 0.5 mM in dimethyl
sulfoxide and stored at 4°C. Bupivacaine was purchased from Sigma,
and BTX was a generous gift of Dr. John Daly (National Institutes of
Health, Bethesda, MD). To conserve the use of BTX, we included this
toxin in the pipette solution at 5 µM final concentration when
needed. This toxin concentration was previously used to demonstrate the
BTX-resistant phenotype in poison-dart frogs (Daly et al., 1980
) and
was high enough to modify >90% of available wild-type
Na+ channels under appropriate conditions.
Whole-cell currents were recorded with Axopatch 200B, filtered at 5 kHz, and collected by pClamp software (Axon Instruments, Foster City,
CA). In some experiments, currents were recorded by EPC-7. After
gigaohm seal formation and establishment of whole-cell voltage clamp,
the cells were dialyzed for ~20 min before data were acquired. Most
of the capacitance and leakage current were canceled by the patch-clamp circuitry and further subtracted by the P/
4 method. An unpaired Student's t test was used to evaluate estimated parameters
(mean ± SEM or fitted values ± SE of the fit); p
values of < 0.05 were considered statistically significant.
| |
Results |
|---|
|
|
|---|
Expression and Gating of D2-S6 Mutant Channels.
We created
lysine mutants in the D2-S6 region of µ1-G783 to µ1-L795
residues. Four of these 13 mutants expressed sufficient Na+ currents in transfected HEK293t cells for
further experiments; these mutants are N784K, L785K, V787K, and L788K
(mutants of G783, L786, N789, L790, F791, L792, A793, L794, and L795
expressed poorly, generally <0.5 nA). The current-voltage families
were recorded and the peak conductance/voltage curves were constructed
(Fig. 2A, right and left, respectively).
The activation parameters of these mutant channels were obtained by a
curve-fitting program and are included in Table
1. The N784K and V787K mutants display V0.5 values similar to those of wild-type
(~
35 mV), whereas L785K and L788K mutants show a significant shift
of
5.2 mV and +19.4 mV, respectively (p < 0.05).
|
|
curve) of these mutants were determined, as
shown in Fig. 2B, and their parameters are listed in Table 1 along with
the wild-type for comparison. The h0.5 values are
similar between wild-type and L788K (~
84 mV) and are shifted
leftward significantly by 6.8 mV for N784K, by 3.7 mV for L785K, and by
8.6 mV for V787K (p < 0.05).
In addition, we used a 10-s conditioning pulse protocol (Fig.
3, inset) that will be used to measure
the voltage-dependent binding of bupivacaine described later. One
mutant µ1-V787K displays significantly altered gating properties;
with a conditioning pulse of
90 mV, less than 10% of
Na+ current remains (Fig. 3, A and B) as if the
slow inactivation is enhanced drastically. About 50% of µ1-V787K
Na+ current is slow inactivated at
132 mV
(e.g., s
) in the µ1-V787K
mutant channels, whereas a reduction of less than 10% is found in the
wild-type (Fig. 3C,
). The remaining lysine mutants, like the
wild-type, show little or no use-dependent phenotype when compared
under identical conditions. These gating alternations in µ1-V787K
mutant channels demonstrate that this residue is important for proper
gating behavior of the Na+ channel slow
inactivation.
|
BTX-Resistant Phenotype of N784K and L788K.
Despite profound
gating changes, µ1-V787K mutant channels remained sensitive to BTX.
When 5 µM BTX was included in the pipette solution, up to 1000 repetitive pulses produced BTX-modified Na+
currents that are not inactivated (Fig.
4C as in wild-type, 4A). The peak
current amplitude of trace 1000P is about half the size of trace 30P, a
result caused by the enhanced use-dependent inhibition of
Na+ current during repetitive pulses. Similar to
µ1-V787K, µ1-L785K mutant channels remained sensitive to BTX
modification as shown in Fig. 4B. Thus, binding of BTX occurs with
mutant channels despite the lysine substitution at these two positions.
|
-helical structure. We
noticed that repetitive pulses also reduced the peak current of
µ1-N784K mutant significantly, albeit with a much slower rate than
µ1-V787K (Fig. 5A, left, versus Fig. 4C). The cause of this
phenomenon is unclear but could be the alteration of an ultraslow
inactivation process.
|
Bupivacaine Sensitivity of Mutants 784K, 785K, 787K, and 788K.
To compare the bupivacaine sensitivity of mutant channels with that of
wild-type channels, we used a pulse protocol (detailed in Fig. 3A) to
measure the voltage-dependent binding of bupivacaine from
180 mV to
50 mV. A conditioning pulse at various voltages was first applied for
10 s to allow the drug binding to reach the steady state, followed
by an interpulse of
140 mV for 100 ms, which allowed drug-free
inactivated channels to return to their resting state. The
bupivacaine-bound channels recover rather slowly with a time constant
of 2 to 4 s at
140 mV (Nau et al., 1999
). Finally, a test pulse
of +30 mV was applied to activate the drug-free resting channels.
Figure 6 shows the results for the
wild-type channels using this pulse protocol in the absence of 100 µM
bupivacaine (Fig. 3B, dashed line). In the presence of 100 µM, at
conditioning voltages of
180 to
140 mV, the bupivacaine block was
constant about 45% (Fig. 6,
). This low-affinity bupivacaine block
corresponds to the block of the resting state of
Na+ channels. The bupivacaine block increased
progressively from voltage
130 to
80 mV until it reached a constant
level of ~95% from
70 to
50 mV. This high-affinity bupivacaine
block is probably caused by the block of the inactivated state of
Na+ channels. Previous studies have shown that
BTX-resistant mutant channels in general have reduced inactivated
affinity toward LAs (Nau et al., 1999
; Wang and Wang, 1999
; Wang et
al., 2000
). In contrast to this general rule, both 784K and 788K
BTX-resistant mutant channels still display comparably high
(inactivated) affinity toward bupivacaine. Figure 6 (
and
,
respectively) shows the voltage-dependent binding of bupivacaine block
in these mutant channels. The s
|
) demonstrates that a lysine substitution of this residue also
does not reduce the binding affinity of bupivacaine. Unfortunately, we
could not use the same pulse protocol to measure the voltage dependence
of inactivated affinity in mutant 787K channels, which seem to have
altered slow inactivation (Fig. 3B). Nevertheless, these results
together suggest that LAs do not interact directly with µ1-784 and
788 residues within the D2-S6 region. Evidently, both BTX and LAs also
do not directly interact with the residue µ1-785.
Dose-Response Curve for KR and
KI Measurements of Mutant Channels.
Knowing the voltage range for the measurement of resting affinity
(KR) and inactivated affinity
(KI) in these lysine mutants, we then
proceeded to determine their KR and
KI values directly at various bupivacaine
concentrations at either
70 mV or
160 mV conditioning voltage (Fig.
7). The KR
and KI values were estimated by curve
fitting and are listed in Table 2. Hill
coefficient was near unity (p = 1.0 to 1.3) for
wild-type and mutant channels, suggesting that there is only one LA
binding site within the
-subunit Na+ channel
protein. Our results from dose-response curves further suggest that
there are no direct interactions between bupivacaine and residues 784, 785, and 788 within the D2-S6 region. The
KI value for 787K cannot be determined
because of its enhanced inactivation gating at
70 mV (Fig. 3, A and
B), nor can the KR value for µ1-V787K be
estimated accurately. Although the estimated
KR value for µ1-V787K at
160 mV seems
significantly lower than that of the wild-type (Fig. 7B; Table 2), this
phenomenon could be caused by inactivated channels at
160 mV
conditioning pulse (Fig. 3B).
|
|
| |
Discussion |
|---|
|
|
|---|
There are two major findings of this report. First, two residues
(µ1-N784K and µ1-L788K) within segment D2-S6 of
-subunit Na+ channels are critical for BTX action but not
the two adjacent residues (µ1-L785K and µ1-V787K). Substitution
with lysine in either the µ1-L784 or the µ1-V788 position renders
the channels completely resistant to 5 µM BTX. Second, although these
two specific residues are critical for BTX action, they remain
sensitive to bupivacaine block. Similar bupivacaine sensitivities are
found in the two mutants µ1-L785K and µ1-V787K. Therefore, no
evidence of a strong or a direct contact is found between the D2-S6
residues and LAs.
Implications about BTX Action.
Thus far we have identified a
cluster of residues at the S6 segments of all four domains that seem to
be important for the action of BTX (Fig. 1B). These residues are
located near the middle region (position 13 to 21; Fig. 1B) of the S6
transmembrane segment, which contains a total of ~28 amino acids and
presumably forms an
-helical structure (Lipkind and Fozzard, 2000
).
The physiological consequences of BTX poisoning are paralysis,
convulsion, and death of the animal. BTX inhibits both fast and slow
inactivation of the wild-type Na+ channel and
shifts the voltage dependence of the activation process toward the
hyperpolarizing direction, which in turn permits the channel to open
persistently even at resting membrane potentials. It is probable that
structural perturbations of D2-S6 segment via a lysine point mutation
occur either distantly or locally in µ1-N784K and µ1-L788K mutants,
which in turn results in the BTX-resistant phenotype. Precisely how the
side chain and the
-carbon backbone structural perturbations cause
the BTX-resistant phenotype in µ1-N784K and µ1-L788K but not
µ1-N784C, L788A, L785K, and V787K mutants remains to be studied.
Implications about LA and Insecticide Actions.
Although D1-S6,
D3-S6, and D4-S6 segments were previously shown to interact with LAs,
no such strong interactions have been detected so far between the D2-S6
segment and the LA drugs. Except in D2-S6, all BTX-resistant
Na+ channels display a greatly reduced binding
affinity toward LAs (Fig. 1B). In general, a reduction in affinity of
~10- to 20-fold was found for the inactivated state in these channels
(Nau et al., 1999
; Wang and Wang, 1999
; Wang et al., 2000
). In
contrast, the LA binding affinity of inactivated BTX-resistant
Na+ channels with mutations in D2-S6 segments is
quantitatively less affected, ~2.6-fold or less
(KI values of 4.5 µM for wild-type and
11.8 µM for L788K mutant channels). This reduction could be caused by
a long-range effect of the positive charge from the lysine residue.
Together, these results suggest that the residues within D2-S6 are not
as near the bound LA molecule in situ as those within the three other
S6 segments. Therefore, the D2-S6 segment represents a unique domain
that is critical for BTX but not for LA action. The fact that the LA
drugs are smaller molecules than the toxin BTX may be the physical
reason why they interact with D1-S6, D3-S6, and D4-S6 but not D2-S6,
even in the inactivated state.
-subunit (Vais et al., 2000| |
Footnotes |
|---|
Received August 28, 2000; Accepted January 23, 2001
This study was supported by National Institutes of Health Grants GM35401 and GM48090.
Send reprint requests to: Dr. Ging Kuo Wang, Department of Anesthesia, Harvard Medical School and Brigham & Women's Hospital, 75 Francis St. Boston, MA 02115. E-mail: wang{at}zeus.bwh.harvard.edu
| |
Abbreviations |
|---|
LA, local anesthetic; BTX, batrachotoxin; HEK, human embryonic kidney.
| |
References |
|---|
|
|
|---|
-benzoate to sodium channels by local anesthetics.
Mol Pharmacol
25:
219-227[Abstract].This article has been cited by other articles:
![]() |
J. H. Chancey, P. E. Shockett, and J. P. O'Reilly Relative resistance to slow inactivation of human cardiac Na+ channel hNav1.5 is reversed by lysine or glutamine substitution at V930 in D2-S6 Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1895 - C1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Sheets and D. A. Hanck Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels J. Physiol., July 1, 2007; 582(1): 317 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. McNulty, G. B. Edgerton, R. D. Shah, D. A. Hanck, H. A. Fozzard, and G. M. Lipkind Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels J. Physiol., June 1, 2007; 581(2): 741 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Lipkind and H. A. Fozzard Molecular Modeling of Local Anesthetic Drug Binding by Voltage-Gated Sodium Channels Mol. Pharmacol., December 1, 2005; 68(6): 1611 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ulbricht Sodium Channel Inactivation: Molecular Determinants and Modulation Physiol Rev, October 1, 2005; 85(4): 1271 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kondratiev and G. F. Tomaselli Altered Gating and Local Anesthetic Block Mediated by Residues in the I-S6 and II-S6 Transmembrane Segments of Voltage-Dependent Na+ Channels Mol. Pharmacol., September 1, 2003; 64(3): 741 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nau, S.-Y. Wang, and G. K. Wang Point Mutations at L1280 in Nav1.4 Channel D3-S6 Modulate Binding Affinity and Stereoselectivity of Bupivacaine Enantiomers Mol. Pharmacol., June 1, 2003; 63(6): 1398 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Cronin, A. O'Reilly, H. Duclohier, and B. A. Wallace Binding of the Anticonvulsant Drug Lamotrigine and the Neurotoxin Batrachotoxin to Voltage-gated Sodium Channels Induces Conformational Changes Associated with Block and Steady-state Activation J. Biol. Chem., March 14, 2003; 278(12): 10675 - 10682. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Maejima, E. Kinoshita, I. Seyama, and K. Yamaoka Distinct Sites Regulating Grayanotoxin Binding and Unbinding to D4S6 of Nav1.4 Sodium Channel as Revealed by Improved Estimation of Toxin Sensitivity J. Biol. Chem., March 7, 2003; 278(11): 9464 - 9471. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Sheets and D. A. Hanck Molecular Action of Lidocaine on the Voltage Sensors of Sodium Channels J. Gen. Physiol., February 3, 2003; 121(2): 163 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Mujtaba, S.-Y. Wang, and G. K. Wang Prenylamine Block of Nav1.5 Channel is Mediated via a Receptor Distinct from That of Local Anesthetics Mol. Pharmacol., August 1, 2002; 62(2): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Scholz Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels Br. J. Anaesth., July 1, 2002; 89(1): 52 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Li, D. Hadid, and D. S. Ragsdale The Batrachotoxin Receptor on the Voltage-Gated Sodium Channel is Guarded by the Channel Activation Gate Mol. Pharmacol., April 1, 2002; 61(4): 905 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Wang, M. Barile, and G. K. Wang A Phenylalanine Residue at Segment D3-S6 in Nav1.4 Voltage-Gated Na+ Channels Is Critical for Pyrethroid Action Mol. Pharmacol., September 1, 2001; 60(3): 620 - 628. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||